U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 09:11:02 UTC 2023
Edited
by admin
on Sat Dec 16 09:11:02 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
29Z5DNL48C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OBILTOXAXIMAB
DASH   INN   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(BACILLUS ANTHRACIS ANTHRAX PROTECTIVE ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL ETI-204 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ETI-204 .KAPPA.-CHAIN, DIMER
Common Name English
OBILTOXAXIMAB [USAN]
Common Name English
obiltoxaximab [INN]
Common Name English
OBILTOXAXIMAB [PURPLE BOOK CDER]
Common Name English
OBILTOXAXIMAB [MI]
Common Name English
ANTHIM
Brand Name English
Obiltoxaximab [WHO-DD]
Common Name English
ETI-204
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 224306
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
NDF-RT N0000192703
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
WHO-ATC J06BB22
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
EU-Orphan Drug EU/3/18/2065
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
Code System Code Type Description
DAILYMED
29Z5DNL48C
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
RXCUI
1746906
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
MERCK INDEX
m11939
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
ChEMBL
CHEMBL3544926
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
USAN
ZZ-114
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
SMS_ID
100000182406
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
HSDB
8336
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
WIKIPEDIA
Obiltoxaximab
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
NCI_THESAURUS
C166561
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
NDF-RT
N0000192702
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY Anthrax Protective Antigen-directed Antibody Interactions [MoA]
FDA UNII
29Z5DNL48C
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
DRUG CENTRAL
5094
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
LACTMED
Obiltoxaximab
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
CAS
1351337-07-9
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
DRUG BANK
DB05336
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
INN
9825
Created by admin on Sat Dec 16 09:11:02 UTC 2023 , Edited by admin on Sat Dec 16 09:11:02 UTC 2023
PRIMARY
From To
1_22 1_96
2_22 2_96
3_23 3_88
4_23 4_88
3_134 3_194
4_134 4_194
1_146 1_202
2_146 2_202
1_222 3_214
2_222 4_214
1_228 2_228
1_231 2_231
1_263 1_323
2_263 2_323
1_369 1_427
2_369 2_427
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL